Skip to content

Curarsi

Active Private limited companyfounded 2020active for 6 yearsBrandstraat 125, 8755 WingeneKBO/BCE: BE 0745.969.392

Lifetime

6 annual accounts with figures on one time axis
peak of €96,725 in 2024
€95,196▼ 1.6%
peak of €63,326 in 2025
€63,326▲ 3.6%
peak of €255,178 in 2024
€10,504▼ 95.9%
€354,017▲ 927%
Board1 name since 2020
1 director
Documentsfilings and deeds
29-05-202663 days before the deadline
2025micro format
Dividend €308,000Equity from €255,178 to €10,504Debts from €34,456 to €354,017

Key points

from the 2025 annual accounts

Equity

€10,504 from €255,178 in 2024

Equity fell by 96% in 1 year.

Turnover

≈ €210,000 estimated

The micro format states no turnover.

Debts

€354,017 97% of the balance sheet
Suppliers 1%Taxes and wages 17%Other 83%

Liquidity

0.98 was 7.64 in 2024

Short-term debts rose from €34,456 to €354,017.

Filings

6 annual accounts 5 late
AprilJune31 JulyOctober202020222024

The 2021 accounts came in latest, 31 days after the end of the period.

Position in the sector

2.9%

Lower solvency than 92% of companies in human health. The sector median is 63.1%, over 21,368 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as Curarsi has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for Curarsi. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 16-04-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0745969392
Incorporation Founding capital of €10,000, 100 shares · Founded by · appointed as director · published on 16-04-2020 · Gazette deed
First establishment Brandstraat 125, Wingene
All 15 events

Comparable companies

same main activity, similar in size and age
Company
Curarsi Wingene €364,521 €95,196 2.9% -
DR. CARMEN CLAUS Kortrijk €343,591 €87,788 43.8% -
Medimmo33 Boussu €365,665 €91,630 8.5% -
Dokter Vanaenrode Michiele Genk €337,383 €96,589 9.0% -
Dr. Carmen Noordman Antwerp €401,305 €103,918 18.2% -
Dr. Lise Van Schepdael Scherpenheuvel-Zichem €320,421 €104,196 95.8% -
Ann Debackere Wingene €290,276 €103,222 64.9% -

These companies have the same main activity as Curarsi: general medical practice (NACE 86210). They are comparable in size and age: total assets between €290,000 and €401,000, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 14-04-2020Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.301.141.2928755 Wingene, since 14-04-2020
Financial year end
31 December
Peppol
Reachable since 05-05-2026
Company details

Annual accounts 2025

€364,521▲ 25.9%
Filing
Filed on 29-05-2026, 63 days before the end of the filing period
Financials

Insights on Curarsi

Curarsi files the micro format. That format states no turnover. The gross margin rose from €76,505 in 2020 to €95,196 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Curarsi

What is the company number of Curarsi?
The company number of Curarsi is 0745.969.392. The VAT number is the same number with BE in front: BE 0745.969.392.
Where is Curarsi based?
The registered office is at Brandstraat 125, 8755 Wingene.Company details
What does Curarsi do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Curarsi?
Curarsi is a private limited company (BV).
When was Curarsi founded?
Curarsi was founded on 14-04-2020.
Is Curarsi still active?
Yes, Curarsi is an active enterprise in the KBO register.
What is the turnover of Curarsi?
The turnover in financial year 2025 is about €210,000. This figure is estimated from the gross margin of €95,196 and 33 comparable companies (NACE 862). It probably lies between €160,000 and €270,000.Financials
Is Curarsi profitable?
In financial year 2025, Curarsi made a profit of €63,326.
Where can I find the annual accounts of Curarsi?
Curarsi filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Curarsi due?
Curarsi must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.